Clinical impact of ghrelin on chronic respiratory infection

Clinical impact of ghrelin on chronic respiratory infection - Ghrelin administration to patients with chronic respiratory infection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002599

Enrollment

Registered

2009-11-01

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic respiratory infection

Interventions

Human ghrelin (2 microgram/kg, 20 mL solution) was intravenously administered to the patients for 30 min at a constant rate before breakfast and dinner for 3 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with low BMI (<21), continuous emptysis of sputum, detection of significant pathogen in the sputum

Exclusion criteria

Exclusion criteria: Patients with diabetes mellitus, severe cardiac disease, liver dysfunction, renal dysfunction, or any infection

Design outcomes

Primary

Measure	Time frame
neutrophil in sputum	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026